2024-10-11 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis

**Company Overview:** Abbott Laboratories is a multinational healthcare company that develops, manufactures, and markets a wide range of healthcare products, including medical devices, pharmaceuticals, nutritionals, and diagnostics. 

**Performance Analysis:**

1. **Relative Performance:**
    * ABT's cumulative return is 107.6%, while the S&P 500 (VOO) has a cumulative return of 134.82%. This shows that ABT has underperformed the S&P 500 by 28.08%. 
    * The relative divergence of -28.08% places it at the 14.21% percentile of its historical performance range.

2. **Recent Price Movement:**
    * Closing Price: $115.95
    * 5-day Moving Average: $113.76
    * 20-day Moving Average: $114.36
    * 60-day Moving Average: $111.36
    * The current price is slightly above the 5-day and 20-day moving averages, suggesting short-term stability. The 60-day moving average is below the current price, indicating a potential upward trend in the medium term.

3. **Technical Indicators:**
    * **RSI:** 61.53, indicating that the stock is in the overbought territory.
    * **PPO:** -0.03, suggesting a slightly bearish momentum in the market.
    * **Delta_Previous_Relative_Divergence:** -10.98, indicating a recent short-term downtrend in relative performance compared to the market.
    * **Expected Return:** 0.0%, suggesting that the expected return is negligible based on the current market conditions.

4. **Recent Earnings and Outlook:**
    * **Latest Earnings:**
        * **Date:** 2024-07-31
        * **EPS:** 0.74
        * **Revenue:** $10.38 Billion
    * The recent earnings report shows that ABT surpassed analysts' expectations for both EPS and revenue. 
    * **Outlook:** The company's future earnings are expected to grow steadily, supported by continued demand for its products and its strong market position.

5. **News and Recent Issues:**
    * **Recent Market Outlook:** ABT is expected to benefit from the aging population and increasing demand for healthcare products. However, the company is also facing challenges such as rising costs and regulatory scrutiny.
    * **Analyst Opinions and Performance Highlights:** Analysts have a generally optimistic outlook on ABT, with most rating it as a buy or hold. The company's strong performance in recent quarters and its focus on innovation have contributed to this positive sentiment.
    * **FINBOLD Reports:** ABT has been consistently recognized by FINBOLD for its strong financial performance and positive future outlook. 

**Overall Analysis:**

While ABT has underperformed the S&P 500 in recent years, its recent earnings performance and positive outlook suggest that the company is well-positioned for growth in the future. The stock is currently in overbought territory, but the strong fundamentals and positive analyst sentiment support its potential for future price appreciation.  

**Investment Recommendation:** 

Given the company's solid fundamentals, its strong market position, and its focus on innovation, ABT could be a valuable addition to a diversified investment portfolio. However, investors should consider the stock's current valuation and monitor its performance closely, as it may be overvalued in the short term. 
